67 completed, 14 recruiting, 10 unknown, 7 terminated. 49 Phase 2, 21 Not applicable, 16 Phase 1, 13 Phase 3, 4 Phase 4.
Follow Fragile X Syndrome: new trials by email Literature Review of Fragile X Syndrome trials Research Report on Fragile X Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess Safety, Tolerability, Pharmacokinetics, and Efficacy of S247240 in Adult Male Participants With Fragile X Syndrome S247240 Low dose, S247240 Middle dose, S247240 High dose - Fragile X Syndrome (FXS) | Phase 2 | Not yet recruiting | Institut de Recherches Internationales Servier (I.R.I.S.) | 100 | 2027-01-25 | 2026-11-12 |
| A Study to Investigate the Effects and Safety of Codabakalner for the Treatment of FXS in Male Participants and Adult Participants With ADS Codabakalner, Placebo - Fragile X Syndrome (FXS), Autism Spectrum Disorder (ASD) | Phase 2 / Phase 3 | Not yet recruiting | Spinogenix | 120 | 2026-12-01 | 2026-10-09 |
| Inhibition of Aggressive Behavior in Participants With Fragile X Syndrome SRX246, Placebo - Aggressive Behavior in Fragile X Syndome | Phase 2 | Not yet recruiting | Azevan Pharmaceuticals | 80 | 2026-12-01 | 2026-10-30 |
| Single Session Support for Parents of Children With Neurodevelopmental Disabilities Struggling With Anxious Avoidance EMPOWER-ND - Neurodevelopmental Disorders, Autism Spectrum Disorder (ASD) | Not applicable | Not yet recruiting | Boston University Charles River Campus | 50 | 2026-11-01 | 2026-10-27 |
| The Neurocognitive Bases of Trust in Intellectual Disability Confidence adjustment assessment, clinical assessment, Cognitive assessment - Down Syndrome (Trisomy 21), Fragile X Syndrome (FXS) | Recruiting | Hospices Civils de Lyon | 112 | 2026-07-17 | 2026-08-05 | |
| Safety, Tolerability, and Preliminary Effectiveness of CTH120 in Fragile X Syndrome CTH120, CTH120 placebo hard capsules - Fragile X Syndrome (FXS), Fragile X Syndrome | Phase 2 | Recruiting | Connecta Therapeutics, S.L. | 30 | 2026-05-21 | 2026-07-17 |
| Optical Imaging in X-linked Disorders. Clinical assessment, Parental questionnaires, Cognitive assessment - Fragile X Syndrome (FXS), Creatine Transporter Deficiency | Not applicable | Recruiting | Hospices Civils de Lyon | 118 | 2026-03-30 | 2026-05-15 |
| Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disorders Neurodevelopmental Disorders, Neurodevelopmental Disorders (NDD) | Recruiting | Healing Hope International | 100 | 2026-03-01 | 2026-03-25 | |
| Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM) Low dose of MRM-3379, Middle Dose of MRM-3379, High dose of MRM-3379 - Fragile X Syndrome | Phase 2 | Recruiting | Mirum Pharmaceuticals, Inc. | 60 | 2025-11-22 | 2026-09-29 |
| Effect of CANnabidiol on Anxiety and GABAergic Function in Individuals With Fragile-X Syndrome CBD Oral Solution, Placebo - Fragile X Syndrome | Phase 2 | Recruiting | Université de Sherbrooke | 40 | 2025-09-01 | 2026-08-28 |
| Effect of CBD on the Brain CBD Oral Solution (eCBD system Target), Placebo - Fragile X Syndrome | Phase 2 | Not yet recruiting | Université de Sherbrooke | 50 | 2025-05-01 | 2025-02-17 |
| Physical Activity and Community EmPOWERment Project PACE Program - Intellectual Disability, Neurodevelopmental Disorders | Not applicable | Recruiting | University of North Carolina, Chapel Hill | 376 | 2025-01-10 | 2026-02-23 |
| Neural Biomarkers in Fragile X Syndrome Any - Fragile X Syndrome (FXS), Neurotypical Adults | Completed | Connecta Therapeutics, S.L. | 20 | 2024-12-16 | 2025-05-04 | |
| Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders Blood sample - Invasive PreNatal Diagnosis in a Context of Family History of Single-gene Disorders, Including, Sickle Cell Disease | Recruiting | Assistance Publique - Hôpitaux de Paris | 550 | 2024-10-23 | 2026-10-21 | |
| Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders Sertraline, Placebo - Neurodevelopmental Disorders, Autism | Phase 2 | Recruiting | Holland Bloorview Kids Rehabilitation Hospital | 130 | 2024-09-16 | 2026-07-27 |
| Study of SPG601 in Adult Men With Fragile X Syndrome SPG601, Placebo - Fragile X Syndrome | Phase 2 | Completed | Spinogenix | 10 | 2024-07-05 | 2026-05-26 |
| Placebo-Controlled, Single-Dose Challenge Study of Gaboxadol in Adult Males With Fragile X Syndrome (FXS) Gaboxadol, Placebo - Fragile X Syndrome | Phase 2 | Completed | Craig Erickson | 10 | 2024-01-29 | 2026-09-30 |
| Probiotic Intervention for Microbiome Modifications and Clinical Improvements in Fragile X Syndrome Probiotics - Fragile X Syndrome | Not applicable | Unknown | Specila hospital for cerebral palsy and developmental neurology | 15 | 2024-01-01 | 2024-06-03 |
| Speech-in-noise Perception in Autism and Fragile X Mismatch negativity - Autism Spectrum Disorder, Fragile X Syndrome | Not applicable | Completed | Children's Hospital Medical Center, Cincinnati | 43 | 2023-11-10 | 2026-11-04 |
| Web Intervention for Parents of Youth With Genetic Syndromes (WINGS) Functional Behavioral Training (FBT), Positive Parenting Strategies-Treatment as Usual - Telomeric 22Q13 Monosomy Syndrome, Tuberous Sclerosis | Not applicable | Active not recruiting | Rush University Medical Center | 79 | 2023-09-15 | 2026-09-18 |
Showing 20 of 115. Sign in to see all of them.
Autism Spectrum Disorder (17) · Intellectual Disability (16) · Autistic Disorder (12) · Down Syndrome (9) · Genetic Diseases, Inborn (8) · Neurodevelopmental Disorders (8) · Neurobehavioral Manifestations (7) · Congenital Abnormalities (6) · Genetic Diseases, X-Linked (6) · Angelman Syndrome (5) · Developmental Disabilities (5) · Prader-Willi Syndrome (5) · Williams Syndrome (5) · Anxiety Disorders (4)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (115) · Heredodegenerative Disorders, Nervous System (115) · Neurologic Manifestations (115) · Sex Chromosome Disorders (113) · Chromosome Disorders (112) · Nervous System Diseases (112) · X-Linked Intellectual Disability (111) · Congenital Abnormalities (109) · Genetic Diseases, X-Linked (109) · Neurobehavioral Manifestations (108) · Genetic Diseases, Inborn (107) · Intellectual Disability (99) · Mental Disorders (43) · Neurodevelopmental Disorders (29) · Pathological Conditions, Signs and Symptoms (24)
mavoglurant (6) · Metformin (5) · arbaclofen placarbil (5) · BPN14770 (4) · Minocycline (4) · gaboxadol (4) · 2-chloro-4-(1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl)pyridine (3) · Acamprosate (3) · Lovastatin (3) · Ascorbic Acid (2) · Baclofen (2) · Donepezil (2) · Mental Status and Dementia Tests (2) · Methylphenidate (2) · Sertraline (2)
Seaside Therapeutics, Inc. (9) · Children's Hospital Medical Center, Cincinnati (8) · Stanford University (7) · Novartis Pharmaceuticals (6) · University of California, Davis (6) · Tetra Discovery Partners (4) · Université de Sherbrooke (4) · Connecta Therapeutics, S.L. (3) · Hoffmann-La Roche (3) · Indiana University (3) · RTI International (3) · Bambino Gesù Hospital and Research Institute (2) · Elizabeth Berry-Kravis (2) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (2) · Hospices Civils de Lyon (2)
United States (82) · Spain (14) · France (13) · Canada (12) · Australia (8) · Italy (8) · United Kingdom (8) · Germany (5) · Switzerland (5) · Denmark (4) · Israel (4) · Belgium (3) · New Zealand (3) · Sweden (3) · Netherlands (2)
Elizabeth Berry-Kravis, MD, PhD (5) · Randi J Hagerman, MD (4) · Allan L Reiss (3) · Bryan King, MD, PhD (3) · Craig Erickson, MD (3) · Craig Erikson, MD (3) · Elizabeth Berry-Kravis, MD (3) · James McCracken, MD (3) · Jeremy Veenstra-VanderWeele, MD (3) · Lawrence Ginsberg, MD (3) · Linmarie Sikich, MD (3) · Paul Wang, M.D. (3) · Randi Hagerman, MD (3)
PMID 26764156, PMID 26855682, PMID 33395098, PMID 35794169, PMID 20937127, PMID 21059347, PMID 21209411, PMID 21862226, PMID 24285681, PMID 24354947, PMID 25187257, PMID 27612457, PMID 28764646, PMID 29875084, PMID 30153790, PMID 30455171, PMID 30982467, PMID 31315600, PMID 31549310, PMID 32316911, PMID 32555262, PMID 32660869, PMID 33218305, PMID 33473111, PMID 33927413, PMID 34690787, PMID 35053752, PMID 35142618, PMID 36167501, PMID 36180840, PMID 36434514, PMID 37850681, PMID 39248107, PMID 39332280, PMID 39483619, PMID 41254489, PMID 41291951, PMID 42104256
2009 (2), K23HD109375 (2), 2025 (1), K23MH077554 (1), R01AG076678 (1), R01HD071987 (1), R01HD076189 (1), R01HD108222 (1), R34MH085899 (1), U01NS096767 (1), U54HD082008 (1), U54HD104461 (1)